Compound Detail
CHEMBL240624
PRELADENANT 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL240624 |
| Name | PRELADENANT |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | DTYWJKSSUANMHD-UHFFFAOYSA-N |
5
Targets
25
Activities
3
Assay Types
6
PK Parameters
20
Publications
4
Known Names
3
Indications
1
Mechanisms
Molecular Properties
503.6
MW (Da)
2.16
ALogP
12
HBA
1
HBD
125.0
PSA (Ų)
0.30
QED
2
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Adenosine A2a receptor antagonist | ANTAGONIST | Adenosine receptor A2a | ✓ | ✓ |
Indications
Parkinson Disease Liver Diseases Neoplasms
Activity Summary
Ki 22 meas. best 9.3
IC50 2 meas. best 8.6
Kd 1 meas. best 9.5
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adenosine receptor A2a CHEMBL251 | Kd | 9.5 | 9.5 | 0.3 | 1 |
| Adenosine receptor A2a CHEMBL251 | Ki | 9.3 | 8.9573 | 0.5 | 15 |
| Adenosine receptor A2a CHEMBL302 | Ki | 9.18 | 8.89 | 0.7 | 2 |
| Adenosine receptor A2a CHEMBL302 | IC50 | 8.6 | 8.6 | 2.5 | 1 |
| Adenosine receptor A1 CHEMBL318 | Ki | 7.16 | 7.16 | 68.7 | 1 |
| Zika virus CHEMBL4296612 | IC50 | 6.87 | 6.87 | 136.1 | 1 |
| Adenosine receptor A1 CHEMBL226 | Ki | 6.53 | 6.34 | 295.0 | 4 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1560.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | - | - | Rattus norvegicus |
| CL | - | - | Homo sapiens |
| CL | 37.0 | mL.min-1.kg-1 | Rattus norvegicus |
| F | 57.0 | % | Rattus norvegicus |
| T1/2 | 2.1 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine